• In memory of Jemma Redmond My journey in this industry started over ten years ago as a young wide-eyed regenerative medicine master’s student at NUI Galway, that suddenly became an “extrusion 3D bioprinting maximalist and deep technology entrepreneur” during my bioengineering British Heart Foundation-funded Ph.D. research scholarship at Imperial College…

    Read More
  • Prior to all of the news surrounding Facebook’s metaverse rebrand and $10 billion investment into the metaverse, the CEO of Ourobionics John Zandbergen and the CEO of blockchain company Cartallum Wynand Oschmann were establishing a partnership in the Netherlands to initiate the development of the first global 3D Biofabrication &…

    Read More
  • 3D Systems (NYSE:DDD) acquired Volumetric Biotechnologies, a Houston-based biotech company co-founded by Drs. Jordan Miller and Bagrat Grigoryan. Volumetric’s mission has from the outset been to develop the ability to manufacture human organs using bioprinting methods. Dr. Miller and his team of bioengineers and scientists have made tremendous progress in…

    Read More
  • First presented at Bio Digital 2020, Rousselot‘s X-Pure GelMA is the world’s first GMP-ready gelatin methacryloyl (GelMA or Gel-MOD) for preclinical and clinical applications in regenerative medicine. GelMA is a gold-standard biomaterial, ideal as a bioink for 3D bioprinting and tissue engineering, owing to its guaranteed ultra-low impurity levels and…

    Read More
  • After so many years of anticipation and excitement for the possibilities it could offer, the bioprinting segment now seems to finally be coming into its own. The bioprinting market is starting to take shape, setting the foundations for future growth, while large medical and pharmaceutical firms look at this field…

    Read More
  • The PhonoGraft biomimetic hearing-restoration technology, advanced through a six-year effort by a multidisciplinary research team at the Wyss Institute for Biologically Inspired Engineering, Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS), and Massachusetts Eye and Ear (MEE)/Mass General Brigham (MGB), has now entered commercial development. If successful,…

    Read More
  • As 3dpbm anticipated in July, CELLINK AB is officially transitioning to BICO, concentrating on the intersection of biology and technology  Since its founding in 2016, BICO has built one of the world’s most expansive portfolios of life science products that spans bioprinting, diagnostics, lab automation and multi-omics among other key…

    Read More
  • Desktop Health has added the PhonoGraft platform to its technology portfolio, with the potential to support the body’s functional and morphological regeneration of the tympanic membrane. This biofabrication technology may also offer a promising pathway for soft tissue regeneration for a wide range of healthcare applications. The PhonoGraft technology was…

    Read More
Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*